Cargando…
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
The advent of next-generation sequencing (NGS) is heavily changing both the diagnosis of human conditions and basic biological research. It is now possible to dig deep inside the genome of hundreds of thousands or even millions of people and find both common and rare genomic variants and to perform...
Autores principales: | Zaghi, Mattia, Banfi, Federica, Bellini, Edoardo, Sessa, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616022/ https://www.ncbi.nlm.nih.gov/pubmed/34827709 http://dx.doi.org/10.3390/biom11111713 |
Ejemplares similares
-
Worthless Drugs
por: Gibbs, E. H.
Publicado: (1875) -
Worthless Quinia Pills
Publicado: (1875) -
The Psychopathology of Worthlessness in Depression
por: Harrison, Phillippa, et al.
Publicado: (2022) -
Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
por: Houssami, Nehmat
Publicado: (2017) -
Assessing Lysosomal Disorders in the NGS Era: Identification of Novel Rare Variants
por: Encarnação, Marisa, et al.
Publicado: (2020)